Back to search
Legg-Calvé-Perthes Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Legg-Calvé-Perthes Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Legg-Calvé-Perthes Disease trials you may qualify forOsteonecrosis of the femoral head (ONFH) presents a rapidly progressive natural disease course. Femoral head collapse may occur within two years, ultimately nec…
A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabu…
Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellula…
A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medic…
This retrospective observational study evaluates the clinical and radiological outcomes of patients with early-stage osteonecrosis of the femoral head treated w…
This trial is a single center, randomized, double-blind, placebo-controlled dose escalation study aimed at examining the safety, tolerability, and pharmacokinet…
This study, titled "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," aims to assess the long-term effectiveness of…